tiprankstipranks
Trending News
More News >
Alterity Therapeutics Ltd. (PRNAF)
OTHER OTC:PRNAF

Compare Alterity Therapeutics (PRNAF) vs. Competitors

Compare
5 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Alterity Therapeutics
$0.01
$61.13M
-8.33
0.00%
1 Buy
0 Hold
0 Sell
Moderate Buy
Imugene
AU$0.33
AU$110.32M
-1.01
-75.87%
Paradigm Biopharmaceuticals
AU$0.33
AU$138.72M
-6.64
-29.03%
EZZ Life Science Holdings Ltd.
AU$1.45
AU$86.09M
12.55
-14.25%
Recce Pharmaceuticals Ltd.
AU$0.41
AU$189.42M
-7.16
40.22%
Arovella Therapeutics Limited
AU$0.08
AU$102.10M
-12.94
-53.68%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PRNAF
Alterity Therapeutics
0.01
0.00
0.00%
AU:IMU
Imugene
0.32
-1.01
-75.87%
AU:PAR
Paradigm Biopharmaceuticals
0.33
-0.21
-38.89%
AU:EZZ
EZZ Life Science Holdings Ltd.
1.84
-0.13
-6.76%
AU:RCE
Recce Pharmaceuticals Ltd.
0.65
0.19
40.22%
AU:ALA
Arovella Therapeutics Limited
0.09
-0.10
-52.43%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts